VB Chemical Research LLC’s Post

🚀 Thrilled to share insights from Jan Haller and Oliver Plietzsch on how hazardous chemistry can be pivotal for optimizing API production. The case of #Oteseconazole (#Vivjoa™) shows how innovation at #Axplora is driving efficiency and life-changing treatments for millions. Learn more about how we’re shaping the future of #DrugDevelopment in #ChemistryToday!

The science and pharmaceutical industries require accurate endpoint determination to improve product yield and production efficiency and minimize waste. ✳ DOWNLOAD✳ Solutions Flyer https://ow.ly/Y1L450Swz0Z ✳Learn more about our solutions for life science and biotechnology applications https://lnkd.in/gVYWsVED #processinsights #gasanalysis #wateranalysis #pharmaceuticals #lifescience #lab #fermentation #alternativeproteins #cellculturecontrol #biotechnology

🚀 We're thrilled to share insights from a recent article in #ChemistryToday by Jan Haller and Oliver Plietzsch, spotlighting the pivotal role of hazardous chemistry in developing commercial-scale processes for Active Pharmaceutical Ingredients (#APIs). The article highlights how to balance risk management with efficiency—key priorities in the pharmaceutical industry. Using the case study of #Oteseconazole (VT-1161), the authors explore the journey from development to scale-up and commercial production. Recently launched as #Vivjoa™ by Mycovia Pharmaceuticals, Oteseconazole is a groundbreaking antifungal treatment for a chronic infection affecting 138 million women worldwide. 📈 Notably, they increased chemical yield from 67% to 86%, while reducing process mass intensity by 55%. This project demonstrates our pioneering approach at #Axplora, where we don’t just react, but seek innovative answers in new places. It’s a testament to how hazardous chemistry, when navigated with seriousness and agility, can produce scalable, life-changing solutions! ⭐ 🔗 https://lnkd.in/gb-jtpn8 #Axplora #HazardousChemistry #ProcessSafety #DrugDevelopment tks | publisher, event organiser, media agency

🌟 Speaker Spotlight: David Weil 🌟 Join us at the Extractables & Leachables Summit West 2024 as we welcome David Weil, Master Application Specialist, Global E&L at Agilent Technologies. This talk will explore the increasing complexity of detecting extractable and leachable (E&L) compounds in biologic drug formulations, particularly in manufacturing with single-use systems and container closure systems. It will also review recent developments in LCMS and GCMS methods for analyzing these compounds, and how new standards and theoretical modeling can improve the identification of E&L compounds from pharmaceutical materials. Don't miss this insightful session from a leading expert in the field! 💥 #PharmaEvents #Pharmaceuticals #ExtractablesAndLeachables #MaterialSelection #PatientSafety #DrugDevelopment #Agilent #GCMS #DrugSafety #EandL #AnalyticalChemistry #PharmaIndustry #Biopharma #RegulatoryCompliance

Global Gas Phase Filtration Market The global SAS phase filtration market is on the rise, with industries like pharmaceuticals and biotechnology driving demand. With technological advancements and increasing regulatory requirements, the market is set for significant growth. Dive into the latest report to explore key trends, challenges, and opportunities in this dynamic market. Stay ahead of the competition by understanding the future of SAS phase filtration systems. Learn more.. https://lnkd.in/e3VeyCbT #SASPhaseFiltration #MarketResearch #Pharmaceuticals #Biotechnology

Runyu Product Show--348 Cas No.:1810068-35-9 MF: C48H44F12N3O5PPdS Abbreviation: Palladacycle Gen.4 Full Name: Methanesulfonato{2-bis[3,5-di(trifluoromethyl)phenylphosphino]-3,6-dimethoxy-2',6'-bis(dimethylamino)-1,1'-biphenyl}(2'-methylamino-1,1'-biphenyl-2-yl)palladium(II) Purity: 98% Runyu（A MIT licensed company） is a manufacturing expert of organic phosphino ligands and precious metal catalysts which are widely used in drug discovery and APIs. -- ISO 9001:2008 Certified -- 100% succeed Onsite/online audit since 2017 -- One research center + two large-scale production workshops -- Supply stable and continuously If interested in, welcome to contact with us: E-mail: yi.ding@runvmat.com #Discovery #drugdiscovery #cro #cdmo #crdmo #CMO #pharmaceutical #pharma #catalyst #lifesciences #biotech #API #drugdevelopment #pharmaceuticalindustry #pharmaceutical #pharmaindustry

🧪💊💊 𝐈𝐧𝐭𝐫𝐨𝐝𝐮𝐜𝐢𝐧𝐠 𝐀𝐜𝐭𝐢𝐯𝐞 𝐏𝐡𝐚𝐫𝐦𝐚𝐜𝐞𝐮𝐭𝐢𝐜𝐚𝐥 𝐈𝐧𝐠𝐫𝐞𝐝𝐢𝐞𝐧𝐭𝐬 𝐛𝐲 𝐓𝐡𝐞 𝐋𝐞𝐞𝐥𝐚 𝐂𝐨𝐫𝐩𝐨𝐫𝐚𝐭𝐢𝐨𝐧🩸🩸🌡 "Embark on a transformative journey with our pioneering chemical company as we unveil our latest endeavor: 𝐀𝐜𝐭𝐢𝐯𝐞 𝐏𝐡𝐚𝐫𝐦𝐚𝐜𝐞𝐮𝐭𝐢𝐜𝐚𝐥 𝐈𝐧𝐠𝐫𝐞𝐝𝐢𝐞𝐧𝐭𝐬 (𝐀𝐏𝐈𝐬). Guided by a commitment to innovation and quality, we're revolutionizing the landscape of healthcare by harnessing the power of precise chemistry. With a steadfast dedication to excellence and safety, we're reshaping the future of medicine, one molecular bond at a time. Join us in shaping a healthier tomorrow with our cutting-edge 𝐀𝐏𝐈 𝐬𝐨𝐥𝐮𝐭𝐢𝐨𝐧𝐬, where every molecule counts, and every life matters." ♻♻♻♻♻♻♻ 𝐂𝐎𝐍𝐓𝐀𝐂𝐓 𝐔𝐒 +𝟗𝟏 𝟗𝟗𝟎𝟗𝟎 𝟒𝟓𝟒𝟐𝟏 | 𝐦𝐚𝐫𝐤𝐞𝐭𝐢𝐧𝐠𝟐@𝐥𝐞𝐞𝐥𝐚𝐜𝐨𝐫𝐩.𝐜𝐨𝐦 #tlc #tlcworldwide #APIs #Active_Pharmaceutical_Ingredients #introducing #pharmaceutical #molecules #pharmaceuticals #pharma #pharmasector #chemistry #chem #chemicals #distributor

Bioreactor Market - Trending Report - 2025-2033 Explore Full Report With Toc: https://lnkd.in/gRxMmiQY The global bioreactor market size was valued at USD 8.0 Billion in 2024. Looking forward, IMARC Group estimates the market to reach USD 19.6 Billion by 2033, exhibiting a CAGR of 10.4% during 2025-2033. North America currently dominates the market, holding a significant market share of over 39.1% in 2024. The increasing adoption of effective treatment drugs, along with the rising need for preventive vaccines, is primarily propelling the market. #Bioreactor #Biotech #Biotechnology #Bioengineering #Bioprocessing #Pharmaceuticals #LifeSciences #Biomanufacturing #HealthcareInnovation #SustainableTechnology #IndustrialBiotechnology #LabTech #BioreactorMarket #ScienceAndInnovation #FutureOfBiotech

"Ultraselective Macrocycle Membranes for Pharmaceutical Ingredients Separation in Organic Solvents" 📚 Summary 👨🏫 A recent study from Nature Communications introduces a breakthrough in membrane technology. Those, made from fully crosslinked crown ethers, show remarkable improvements in selectivity and solvent permeance, achieving up to 90% higher selectivity than existing commercial membranes. Why It’s Interesting 💡 This approach offers significant advancements for the pharma industry. The ability to efficiently separate and retain active pharmaceutical ingredients (APIs) with molecular weights around 800 g/mol could revolutionize how we process and purify sensitive compounds ! In NUVISAN The Science CRO, we have expertise in API synthesis, separation and characterization ? DM me or comment "API" to get more informations about our capabilities ! #Chemistry #Pharmaceuticals #MembraneTechnology #DrugDevelopment #SeparationProcesses #Nanofiltration #NatureCommunications #Innovation

𝗦𝗖𝗖𝗜𝗝 𝗡𝗲𝘄𝘀: "𝗦𝘄𝗶𝘀𝘀 𝗰𝗵𝗲𝗺𝗶𝗰𝗮𝗹𝘀 𝗮𝗻𝗱 𝗽𝗵𝗮𝗿𝗺𝗮 𝗶𝗻𝗱𝘂𝘀𝘁𝗿𝘆'𝘀 𝗰𝗼𝗺𝗺𝗶𝘁𝗺𝗲𝗻𝘁 𝘁𝗼 𝘀𝘂𝘀𝘁𝗮𝗶𝗻𝗮𝗯𝗶𝗹𝗶𝘁𝘆 𝘀𝗲𝗰𝘂𝗿𝗲𝘀 𝘁𝗼𝗽 𝘀𝗽𝗼𝘁" 𝘍𝘶𝘭𝘭 𝘢𝘳𝘵𝘪𝘤𝘭𝘦: https://lnkd.in/gVnr_x3S The top position in a new ranking confirms the Swiss #chemicals and #pharmaceutical industry's pioneering role in #ecological #sustainability.